AI-Driven Oncology Data Platforms Under Siege: Why LARVOL’s Breakthrough Demands Zero-Trust Security Now + Video
Introduction: The European Commission’s recent approval of Trodelvy® (sacituzumab govitecan-hziy) as a first-line treatment for metastatic triple-1egative breast cancer marks […]









